
Practice Location
Hannacell Dermatology
Profile
Academic Background and Professional Qualifications
Dr. Han-na Kwon is a senior expert in family medicine, holding a Doctor of Medicine degree from Yonsei University College of Medicine, where she serves as an adjunct professor. She maintains a close connection between academic research and clinical practice, dedicated to translating cutting-edge medical theories into practical diagnostic and treatment protocols.
Career History and Clinical Experience
Dr. Kwon has deep expertise in aesthetic medicine and regenerative medicine, having previously served as the Director of Dermatology at Wonjin Plastic Surgery Clinic, the Director of the Wonjin Stem Cell Center, and the Director of the HARVEST Stem Cell Center. With 13 years of clinical experience in stem cell therapy, she has accumulated extensive expertise in managing complex cases. Her surgical case volume ranks among the highest for specialists in South Korea, demonstrating high clinical activity and technical maturity.
International Academic Standing and Collaboration
As an active member of the international regenerative medicine community, Dr. Han-na Kwon is a member and council member of the American Academy of Regenerative Medicine (AARM), as well as a formal member of IMCAS (World Society of Aesthetic Plastic Surgery) and AMWC (World Congress of Anti-Aging Medicine). She enjoys a good reputation in prominent international academic organizations and actively participates in global academic exchanges and technological collaborations.
Research Achievements and Technical Standards
In terms of research, Dr. Kwon participated in a stem cell bank project developed by the IDI Immunology Institute at Harvard Medical School, which ranks among the top globally. The related technologies and processes strictly adhere to international standards and have received multiple certifications and approvals from the U.S. Food and Drug Administration (FDA), the British Standards Institution (BSI), and the Korean Ministry of Food and Drug Safety (MFDS, formerly KFDA), ensuring the safety and standardization of the treatment process.
Distinctive Features of Treatment
- Precision Family Medicine Management: Leveraging the holistic perspective of family medicine, providing comprehensive health assessments and long-term health management recommendations.
- Application of Cutting-Edge Regenerative Medicine: Relying on 13 years of stem cell therapy experience, utilizing stem cell technology certified by authoritative international institutions, with a focus on the scientific rigor and safety of treatments.
- International Diagnostic and Therapeutic Perspective: Integrating research achievements from top institutions such as Harvard Medical School with the latest international diagnostic and therapeutic guidelines to provide patients with healthcare services that meet global standards.
